Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Farquharson

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Archives of Disease in Childhood. Education and Practice Edition|August 22, 2022
Immediate kangaroo care significantly reduces mortality at 28 days for low-birthweight infantsSarah Farquharson
Journal of Paediatrics and Child Health|June 2, 2021
Neonatal Sound Exposure During Respiratory SupportSarah Farquharson, Rebecca O'Neill, Lorraine McGrory, et al.
Obstetrics and Gynecology|May 3, 2013
Maternal and neonatal outcomes of successful Kielland's rotational forceps deliverySarah J Stock, Katherine Josephs, Sarah Farquharson, et al.
JAMA Pediatrics|April 20, 2026
Cerebral Oximetry in Extremely Preterm Infants: 2-Year Follow-Up of the SafeBoosC-III Randomized Clinical TrialMarie Isabel Skov Rasmussen, Mathias L Hansen, Adelina Pellicer, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Archives of Disease in Childhood. Education and Practice Edition|August 22, 2022
Immediate kangaroo care significantly reduces mortality at 28 days for low-birthweight infantsSarah Farquharson
Journal of Paediatrics and Child Health|June 2, 2021
Neonatal Sound Exposure During Respiratory SupportSarah Farquharson, Rebecca O'Neill, Lorraine McGrory, et al.
Obstetrics and Gynecology|May 3, 2013
Maternal and neonatal outcomes of successful Kielland's rotational forceps deliverySarah J Stock, Katherine Josephs, Sarah Farquharson, et al.
JAMA Pediatrics|April 20, 2026
Cerebral Oximetry in Extremely Preterm Infants: 2-Year Follow-Up of the SafeBoosC-III Randomized Clinical TrialMarie Isabel Skov Rasmussen, Mathias L Hansen, Adelina Pellicer, et al.
Pageof 1